Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.60p
   
  • Change Today:
      1.48p
  • 52 Week High: 19.00
  • 52 Week Low: 4.50
  • Currency: UK Pounds
  • Shares Issued: 226.75m
  • Volume: 1,172,667
  • Market Cap: £14.97m

Ondine reports significant financial growth

By Josh White

Date: Wednesday 24 Apr 2024

LONDON (ShareCast) - (Sharecast News) - Ondine Biomedical reported significant growth in a trading update on Wednesday, with revenues doubling to $1.2m in 2023, driven by expanded hospital deployments of 'Steriwave'.
The AIM-traded company said it now served 24 hospitals, including strategic gains in the UK and Spain, and its first deployment in Australia.

It said discussions were underway for distribution partnerships to accelerate market penetration.

Ondine was also entering the ICU market to replace mupirocin, and finalising plans for a US phase three clinical trial.

Funding support was expected from existing shareholders, while discussions with Health Insight Capital for the clinical trial were ongoing.

At 1211 BST, shares in Ondine Biomedical were down 3.7% at 6.5p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OBI Market Data

Currency UK Pounds
Share Price 6.60p
Change Today 1.48p
% Change 28.78 %
52 Week High 19.00
52 Week Low 4.50
Volume 1,172,667
Shares Issued 226.75m
Market Cap £14.97m

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.6% below the market average47.6% below the market average47.6% below the market average47.6% below the market average47.6% below the market average
72.55% below the sector average72.55% below the sector average72.55% below the sector average72.55% below the sector average72.55% below the sector average
Price Trend
89.75% below the market average89.75% below the market average89.75% below the market average89.75% below the market average89.75% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Income Not Available
Growth
45.42% below the market average45.42% below the market average45.42% below the market average45.42% below the market average45.42% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

OBI Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:45 27,427 @ 6.60p
16:45 2,571 @ 6.60p
16:45 19,285 @ 6.60p
16:45 1,822 @ 6.60p
16:45 749 @ 6.60p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page